CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 87 filers reported holding CASI PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 150 | -90.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 1,500 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -50.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | +100.0% | 1,500 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | -50.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,934,000 | 16.36% |
| Wellington Shields & Co., LLC | 1,585,609 | $3,964,000 | 1.74% |
| Wellington Shields Capital Management, LLC | 1,321,745 | $3,304,000 | 0.53% |
| Ikarian Capital, LLC | 1,039,910 | $2,600,000 | 0.21% |
| Zebra Capital Management LLC | 50,658 | $127,000 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 139,183 | $348,000 | 0.02% |
| Manatuck Hill Partners, LLC | 15,090 | $38,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 205,200 | $513,000 | 0.01% |
| IHT Wealth Management, LLC | 26,000 | $65,000 | 0.01% |
| Vident Investment Advisory, LLC | 67,540 | $169,000 | 0.01% |